Skip to Main Content

Paper Details

Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR<sup>+</sup>, HER2<sup>-</sup> Advanced Breast Cancer.
Clin Cancer Res
10
2020
Author NameAffiliation
Aditya BardiaMassachusetts General Hospital, Harvard Medical School
Luc DirixSint Augustinus Hospital
  • 1 - 2

Datasets

Release 1.2